1. TNBC Therapeutics Based on Combination of Fusarochromanone with EGFR Inhibitors
   Natalie Carroll et al, 2022, Biomedicines CrossRef
2. Fusarochromene, a novel tryptophan-derived metabolite from Fusarium sacchari
   James W. Marshall et al, 2021, Organic & Biomolecular Chemistry CrossRef
3. Use of in-silico assays to characterize the ADMET profile and identify potential therapeutic targets of fusarochromanone, a novel anti-cancer agent
   Madison Wynne El-Saadi et al, 2015, In Silico Pharmacology CrossRef
4. Fusarochromanone-induced reactive oxygen species results in activation of JNK cascade and cell death by inhibiting protein phosphatases 2A and 5
   Ying Gu et al, 2015, Oncotarget CrossRef
5. Fusarochromanone Induces G1 Cell Cycle Arrest and Apoptosis in COS7 and HEK293 Cells
   Ying Gu et al, 2014, PLoS ONE CrossRef
6. Design, synthesis, and biological activities of 3-((4,6-diphenylpyrimidin-2-ylamino)methylene)-2,3-dihydrochromen-4-ones
   Soon Young Shin et al, 2022, Bioorganic Chemistry CrossRef
7. Concise Synthesis of Fungal Metabolite (+)-Fusarochromanone via Rhodium(III)-catalyzed Oxidative sp2C–H Bond Olefination
   Yuji Takahama et al, 2016, Chemistry Letters CrossRef
8. The antitumor activity of naturally occurring chromones: A review
   Ya-di Duan et al, 2019, Fitoterapia CrossRef